Table 4.

Theranostic nanoparticles for injured arteries.

Carrier Nanoparticle material	Imaging agent and imaging modality	Therapeutics/drugs	Target	Binding ligand	Disease	Ref.
Iron oxide nanoparticles	Iron oxide- MRI	Endothelial cell	Arterial stent	Magnetic target	Injured arteries after stent, lack of reendothelization	121
Perfluorocarbon nanomaterials	Perfluorocarbon - MRI	Doxorubicin and paclitaxel	Smooth muscle cell membranes	Tissue factor	In-stent restenosis	122
Perfluorocarbon nanoparticles	Perfluorocarbon - MRI	Rapamycin	Vitronectin on the injured vessel wall	avb3-integrin	Vascular injury; in-stent restenosis	123